Detailed View
RLAY - Relay Therapeutics, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
2,472,107,264
Adj EBIT (TTM)
-296,459,000
Enterprise Value
2,267,518,264
Last Price
12.92
Earnings Yield
-13.07%
Return on Capital
-44.26%
Capital
669,862,000
1Y Price Chart
Last Price: $12.92
1Y Change: 310.16%
As of 2026-05-06 | 1Y Change: 310.16%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 3,000,000 | -78,590,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 6,999,000 | -60,631,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -80,391,000 |
| 2025-06-30 | 10-Q | 2025 | 677,000 | -76,847,000 |
| 2025-03-31 | 10-Q | 2025 | 7,679,000 | -84,869,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | -10,007,000 | -84,979,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -96,369,000 |
| 2024-06-30 | 10-Q | 2024 | 10,007,000 | -100,757,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.